Cyclerion Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (9)

Latest Posts

About This Stock More About This Stock
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics, And More
Article By: Benzinga
Saturday, May 8, 2021 1:32 PM EDT
Insider buying can be an encouraging signal for investors, especially when markets are near all-time highs. Some insiders have taken advantage of initial public offerings. A few chief executive officers were among those buying shares this past week.
In this article: AAT, WY, INTC, TRUP, ALDX, ANAB, APAM, KDP, CYCN, HOWL
Read
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
Article By: Benzinga
Sunday, October 18, 2020 2:39 PM EDT
Biopharma stocks, which started the week on a firm footing, lost momentum mid-way through amid market-wide sell-off triggered by waning stimulus hopes.
In this article: JNJ, PFE, ALNY, OMER, SPPI, VRTX, ZSAN, CYCN, ATXI, CYCC
Read
The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance
Article By: Benzinga
Friday, November 1, 2019 7:38 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours.
In this article: AMGN, BGNE, MNK, PRTK, IDYA, CDNA, BLUE Also: HOTH, AGN, AZN, BMY, GSK, RMD, ACOR, ACRX, ALIM, AMAG, BCRX, CERS, IMGN, NURO, RMTI, CELG, VRTX, ABBV, AGIO, REPH, RETA, PRTO, MGNX, OPGN, MGEN, DOVA, DRNA, DCPH, TRVI, OYST, RAPT, ARDS, MIRM, ITRM, COCP, CYCN, GMAB
Read

Latest Tweets for $CYCN

No tweets yet!

PARTNER HEADLINES